TABLE 1.
Disease status (no. of patients) | AFB smear status (no. of patients) | Radiological appearance (no. of patients) | Lymphocyte profile
|
No. (%) of patients screened for antibodies to PPE-C
|
|||||
---|---|---|---|---|---|---|---|---|---|
Absolute cell count
|
% Cells
|
||||||||
T | CD4 | CD4 | CD8 | B | Positive | Negative | |||
HIV+ subclinical TB (21) | ND | ND | 225-3,350 | 9-525 | 1-23 | 31-82 | 1-25 | 17 (81) | 4 (19) |
HIV+ TB+ (24)a | Positive (16) | Cav. (2)d; non-cav. (14)b | 155-3,962 | 7-552 | 1-29 | 24-71 | 3-29 | 13 (81)d | 3 (19) |
Negative (7) | Cav. (0); non-cav. (7)c | 467-1,309 | 71-332 | 9-22 | 46-70 | 2-19 | 3 (43) | 4 (57) | |
HIV+ TB− (20) | ND | ND | 641-2,698 | 108-862 | 8-54 | 19-72 | 3-27 | 3 (15) | 17 (85) |
HIV− TB+ (30) | Positive (30) | Cav. (30); non-cav. (0) | ND | ND | ND | ND | ND | 29 (97) | 1 (3) |
HIV− TB− HH contact (19) | ND | ND | ND | ND | ND | ND | ND | 2 (11) | 17 (89) |
For one patient, AFB smear and radiographic results were not available.
Eight patients had infiltration, one had patchy areas, one had pleural effusion, and four showed no pulmonary changes.
One patient had infiltration, one had patchy areas, and five showed no pulmonary changes.
Both cavitary-TB patients were positive for antibodies to PPE-C.
ND, not done; cav., cavitary TB; non-cav., non-cavitary TB.